Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PDAC (Trybeca-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03665441
Recruitment Status : Not yet recruiting
First Posted : September 11, 2018
Last Update Posted : September 20, 2018
Sponsor:
Information provided by (Responsible Party):
ERYtech Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2020